Cite
HARVARD Citation
Sun, G. et al. (n.d.). DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia. Cancer medicine. pp. 6393-6402. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sun, G. et al. (n.d.). DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia. Cancer medicine. pp. 6393-6402. [Online].